Acute Neural and Immune Effects of Alcohol in People Living with HIV Infection

酒精对艾滋病毒感染者的急性神经和免疫影响

基本信息

  • 批准号:
    10666599
  • 负责人:
  • 金额:
    $ 33.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-01 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT ABSTRACT HIV infection and heavy alcohol use independently cause inflammation in systemic and neural immune systems through multiple mechanisms. Both HIV and alcohol induce microbial translocation from the gut, systemic immune activation, compromise of the blood-brain barrier, and neuroinflammation. Because 15% of people living with HIV (PLWH) report heavy drinking in the past 30 days, the potential for alcohol to exacerbate immunological and neural dysfunction in HIV is a serious public health concern. Observational research links alcohol use in PLWH to brain abnormalities, cognitive impairment, and increased mortality. However, direct experimental evidence on alcohol-HIV interactions in humans is scarce. COBRE CADRE Research Project 1 (RP1) will investigate whether alcohol use in the context of HIV infection exacerbates inflammatory signaling in the peripheral immune system and central nervous system. Specifically, the study will examine acute effects of moderate alcohol consumption on immune biomarkers, neurometabolites, brain white matter, and cognition in PLWH and healthy controls. We will recruit 48 moderate drinkers who differ on HIV serostatus (24 seropositive individuals, 24 seronegative matched controls) to participate in controlled beverage administration and magnetic resonance imaging (MRI). Participants will be randomized to consume placebo (0 g alcohol/kg body weight) or alcoholic beverage (.60 g/kg; target blood alcohol=.07g/dL). Blood samples will be taken at baseline and for 3 hours after beverage consumption and assayed for plasma biomarkers of microbial translocation, monocyte/macrophage activation, and cytokine response. The plasma ratio of kynurenine to tryptophan will be used as a measure of immune activation relevant to HIV and drinking behavior. Cognition and subjective intoxication will be assessed during the experiment using the standardized measures from the COBRE Clinical Laboratory Core. MRI scans will be collected on the descending limb of alcohol and will focus on correlates of neuroinflammation, including: 1) neurometabolites (choline, Glx, glutathione) in thalamus and frontal white matter, using MR spectroscopy; 2) white matter diffusivity and extracellular free water, using diffusion-weighted imaging (DWI). We hypothesize that alcohol will induce greater pro-inflammatory effects in PLWH, relative to controls, 1) in the peripheral immune system, as reflected in plasma biomarker perturbations and tryptophan degradation; 2) in the brain, as reflected in neurometabolic changes, diffusivity alterations, and increased extracellular water. An exploratory aim tests the prediction that PLWH will show greater subjective intoxication and cognitive impairment in the alcohol condition. The interdisciplinary research team and mentors have experience and expertise in biobehavioral alcohol-HIV research to enable successful completion of this project. RP1 aligns with the overarching COBRE CADRE goal: to identify mechanisms through which substance use exacerbates adverse health outcomes in chronic disease. Results will advance understanding of pathogenic mechanisms of alcohol use and inform efforts to prevent and treat alcohol-related harms, particularly in PLWH.
项目摘要 HIV感染和大量饮酒独立地引起全身和神经免疫系统的炎症。 通过多种机制。艾滋病毒和酒精都会诱导肠道微生物移位, 全身免疫激活、血脑屏障受损和神经炎症。因为15%的 艾滋病毒感染者(PLWH)报告在过去30天内大量饮酒,酒精可能会加剧 HIV免疫和神经功能障碍是一个严重的公共卫生问题。观察研究链接 酒精的使用对PLWH的大脑异常,认知障碍和死亡率增加。然而,直接 关于酒精与艾滋病毒在人体内相互作用的实验证据很少。COBRE CADRE研究项目1 (RP1)将研究在HIV感染的情况下饮酒是否会加剧炎症信号, 外周免疫系统和中枢神经系统。具体而言,该研究将研究 适度饮酒对免疫生物标志物、神经代谢物、脑白色物质和认知的影响 PLWH和健康对照。我们将招募48名中度饮酒者,他们的HIV血清状态不同(24名血清阳性 个体,24个血清阴性匹配对照)参与受控饮料施用, 磁共振成像(MRI)。受试者将随机摄入安慰剂(0 g酒精/kg体重 体重)或酒精饮料(0.60 g/kg;目标血液酒精= 0.07 g/dL)。将在基线时采集血液样本 并在饮用饮料后3小时内检测微生物易位的血浆生物标志物, 单核细胞/巨噬细胞活化和细胞因子应答。犬尿氨酸与色氨酸的血浆比率将为 用于衡量与艾滋病毒和饮酒行为相关的免疫激活。认知与主观 在实验过程中,将使用COBRE临床试验的标准化测量方法评估中毒情况。 实验室核心MRI扫描将收集酒精的下行分支,并将重点关注以下相关因素: 神经炎症,包括:1)丘脑和额叶白色神经代谢产物(胆碱、Glx、谷胱甘肽) 2)白色物质扩散率和细胞外游离水,使用扩散加权 磁共振弥散成像(DWI)。我们假设,酒精会诱导PLWH更大的促炎作用,相对于 对照,1)外周免疫系统,如血浆生物标志物扰动和色氨酸 降解; 2)在大脑中,反映在神经代谢变化,扩散率改变和增加 胞外水一个探索性的目标测试预测,PLWH将显示更大的主观中毒 和认知障碍。跨学科的研究团队和导师有 在生物行为酒精-艾滋病毒研究方面的经验和专业知识,使该项目能够成功完成。 RP 1与COBRE CADRE总体目标一致:确定物质使用的机制 加剧了慢性病的不良健康后果。结果将促进对致病性 酒精使用的机制,并为预防和治疗酒精相关伤害的努力提供信息,特别是在PLWH中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mollie A Monnig其他文献

Mollie A Monnig的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mollie A Monnig', 18)}}的其他基金

Acute Neural and Immune Effects of Alcohol in People Living with HIV Infection
酒精对艾滋病毒感染者的急性神经和免疫影响
  • 批准号:
    10259692
  • 财政年份:
    2019
  • 资助金额:
    $ 33.55万
  • 项目类别:
Immune Activation and Neurodegeneration in HIV Infection and Heavy Drinking
HIV 感染和酗酒中的免疫激活和神经变性
  • 批准号:
    10373467
  • 财政年份:
    2016
  • 资助金额:
    $ 33.55万
  • 项目类别:
Immune Activation and Neurodegeneration in HIV Infection and Heavy Drinking
HIV 感染和酗酒中的免疫激活和神经变性
  • 批准号:
    9197556
  • 财政年份:
    2016
  • 资助金额:
    $ 33.55万
  • 项目类别:
White Matter Integrity and Alcohol Use Disorders
白质完整性和酒精使用障碍
  • 批准号:
    8397589
  • 财政年份:
    2012
  • 资助金额:
    $ 33.55万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.55万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 33.55万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.55万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.55万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.55万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.55万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.55万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 33.55万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 33.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 33.55万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了